Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2024Clinical Toxicology

Characterization of hypofibrinogenemia following rattlesnake envenomation treated with crotalidae immune F(ab’) 2 (equine) antivenom

View Full Paper
Ask AI
Bookmark
Share

Authors

TMThom S. MaciulewiczDADavid R. AxonFSFarshad M. Shirazi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maciulewicz et al. (2024) studied this question.

synapsesocial.com/papers/68e57665b6db643587516461https://doi.org/10.1080/15563650.2024.2406427
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab’)2 antivenoms2022 · 14 citations
  2. 2Exploring the Venom Proteome of the Western Diamondback Rattlesnake, Crotalus atrox, via Snake Venomics and Combinatorial Peptide Ligand Library Approaches2009 · 184 citations
  3. 32022 Annual Report of the National Poison Data System <sup>®</sup> (NPDS) from America’s Poison Centers <sup>®</sup> : 40th Annual Report2023 · 224 citations
  4. 4Comparison of F(ab’) <sub>2</sub> versus Fab antivenom for pit viper envenomation: A prospective, blinded, multicenter, randomized clinical trial2014 · 119 citations